The hemorrhage risk of dasatinib therapy
Blood
.
2023 Jun 15;141(24):2917-2918.
doi: 10.1182/blood.2023020399.
Authors
Giulia Pontarollo
1
,
Christoph Reinhardt
1
Affiliation
1
Johannes Gutenberg University Medical Center.
PMID:
37318908
DOI:
10.1182/blood.2023020399
No abstract available
Publication types
Editorial
Comment
MeSH terms
14-3-3 Proteins*
Dasatinib / adverse effects
Hemorrhage / chemically induced
Humans
Inflammation
Pyrimidines* / adverse effects
Substances
Dasatinib
14-3-3 Proteins
Pyrimidines